The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Neurotoxicity of Alzheimer’s disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
Open accessAbstract
The amyloid peptides Aβ(40) and Aβ(42) of Alzheimer's disease are thought to contribute differentially to the disease process. Although Aβ(42) seems more pathogenic than Aβ(40), the reason for this is not well understood. We show here that small alterations in the Aβ(42):Aβ(40) ratio dramatically affect the biophysical and biological properties of the Aβ mixtures reflected in their aggregation kinetics, the morphology of the resulting amyloid fibrils and synaptic function tested in vitro and in vivo. A minor increase in the Aβ(42):Aβ(40) ratio stabilizes toxic oligomeric species with intermediate conformations. The initial toxic impact of these Aβ species is synaptic in nature, but this can spread into the cells leading to neuronal cell death. The fact that the relative ratio of Aβ peptides is more crucial than the absolute amounts of peptides for the induction of neurotoxic conformations has important implications for anti-amyloid therapy. Our work also suggests the dynamic nature of the equilibrium between toxic and non-toxic intermediates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased Aβ 42:40 ratio in oligodendrocytes could contribute to the high proportion of soluble aggregates [28,42,43]”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Aβ40 is present in larger amounts in the brain, yet Aβ42 is more neurotoxic and has a higher tendency to aggregate.8–11”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the longer and more hydrophobic Aβ42 isoform has a higher tendency to generate neurotoxic oligomeric species.9,10”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although Aβ40 is present in larger amounts in the brain, Aβ42 was found to be more neurotoxic and have a higher tendency to aggregate.4,5”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Although it was shown in previous studies9,10,21 that the Aβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“…potently disrupt synaptic plasticity (Klyubin et al, 2008; Shankar et al, 2008), an Ab species of 56 kDa has been found neurotoxic in Tg2576 mice (Lesne et al, 2006), lipid-induced oligomers from mature fibrils (Martins et al, 2008), ADDLs (Lambert et al, 1998; Gong et al, 2003; Lacor et al,…”
BackgroundRetractedThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
Flagged first, then by citations
1 of the 61 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 538
The stability and dynamics of the Aβ40/Aβ42 interlaced mixed fibrils
Jana, A. K., Güven, O., & Yaşar, F. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2280765 · Cited by 7
Guan, Y., Li, Y., Gao, W., Mei, J., Xu, W. W., Wang, C., & Ai, H. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00585 · Cited by 7
Amyloid β Hypothesis in the Development of Therapeutic Agents for Alzheimer’s Disease
Adeniji, A. O., Adams, P. W., & Mody, V. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00007-6 · Cited by 7
Scan-Find-Scan-Model: Discrete Site-Targeted Suppressor Design Strategy for Amyloid-β
Bhagavatula, H., Sarkar, A., Santra, B., & Das, A. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00272 · Cited by 7
Amyloid-β/Drug Interactions from Computer Simulations and Cell-Based Assays
Nguyen, P. H., del Castillo‐Frias, M. P., Berthoumieux, O., Faller, P., Doig, A. J., & Derreumaux, P. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179902 · Cited by 7
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Liang, J. J., Pitsillou, E., Man, A. Y. L., Madzima, S., Bresnehan, S. M., Nakai, M. E., Hung, A., & Karagiannis, T. C. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107271 · Cited by 6
Exploring Heparan Sulfate Proteoglycans as Mediators of Human Mesenchymal Stem Cell Neurogenesis
Petersen, S. I., Okolicsanyi, R. K., & Haupt, L. M. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01463-8 · Cited by 8
MURAKOSHI, Y., Takahashi, T., & Mihara, H. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201202762 · Cited by 6
de Mena, L., Smith, M. A., Martin, J., Dunton, K. L., Ceballos‐Diaz, C., Jansen‐West, K. R., Cruz, P. E., Dillon, K. D., Rincón-Limas, D. E., Golde, T. E., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00698-z · Cited by 6
Insights into β-amyloid transition prevention by cucurbit[7]uril from molecular modeling
de Oliveira, O. V., Gonçalves, A. D. S., & de Almeida, N. E. C. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1932600 · Cited by 6
Tiedt, H. O., Benjamin, B., Niedeggen, M., & Lueschow, A. (2018) · Neurodegenerative Diseases · doi:10.1159/000485899 · Cited by 6
Yang, B., Cai, Z., Zhang, W., Yin, D., Zhao, W., & Yang, M. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10069 · Cited by 6
Buchholz, S., Bell, M. J., Kabbani, M. A. A., Kluge, L., Cagkmak, C., Klimek, J., & Zempel, H. (2022) · Research Square · doi:10.21203/rs.3.rs-2277268/v1 · Cited by 6
Bagheri, S., & Saso, L. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1704653 · Cited by 6
Yan, C., Kong, Z., Pan, Y., Fu, Z., Han, K., Zhao, X., Zhang, J., Bo, L., 孙维绎, Gao, J., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114710 · Cited by 5
Dong, X., Zhang, Z., Zhao, D. Y., Liu, Y., Meng, Y., Zhang, Y., Zhang, D., & Liu, C. (2015) · Scientific Reports · doi:10.1038/srep13897 · Cited by 5
Sarroca, S., Molina‐Martínez, P., Aresté, C., Etzrodt, M., de Frutos, P. G., Gasa, R., Antonell, A., Molinuevo, J. L., Sánchez‐Valle, R., Saura, C. A., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.002 · Cited by 6
Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?
Li, J., Huang, L., Liu, F., Tang, B., & Yan, X. (2017) · BMC Neurology · doi:10.1186/s12883-017-0942-y · Cited by 5
FT-Raman study of protein misfolding and renaturation in brain hippocampus
Balgoon, M. J., Ahmed, G. A.-R., & Qusti, S. Y. (2018) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2018.08.001 · Cited by 5
Alzheimer's Disease: From Animal Models to the Human Syndrome
Orta‐Salazar, E., Vargas-Rodríguez, I., Castro-Chavira, S. A., Feria‐Velasco, A., & Díaz-Cintra, S. Y. (2016) · InTech eBooks · doi:10.5772/64619 · Cited by 6
Protective ApoE variants support neuronal function by extracting peroxidated lipids
Ralhan, I., Do, A. D., Bae, J.-Y., Feringa, F. M., Cai, W., Chang, J., Chik, K., Lee, N. Y., Gerry, C., van der Kant, R., et al. (2025) · bioRxiv · doi:10.1101/2025.03.05.641722 · Cited by 4
Yang, J., Tsourdinis, G. E., Holas, C., Maienschein‐Cline, M., Lalonde, R., & Fukuchi, K.-I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1694824 · Cited by 4
Vyver, M. V., Daeninck, L., Smet, G. D., Aourz, N., Sahu, S., Engelborghs, S., Pauwels, K., Bundel, D. D., & Smolders, I. J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1239140 · Cited by 5
Pang, Y., Jia, D., Ye, F., Liu, F., Li, J., Zhu, S., Wang, B., Yao, M., Du, L., Yang, C., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.06.014 · Cited by 4
Johansson, L., Sandberg, A., Nyström, S., Hammarström, P., & Hallbeck, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16201 · Cited by 4
Shirian, S., Tahmasebian, N., Moghadam, B. B., Kiani, F. Z., & Amini, M. R. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.3.103 · Cited by 4
Systematic Search for a Predictor for the Clinical Observables of Alzheimer’s Disease
Das, A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c06725 · Cited by 4
AFM investigation of the aggregation behavior of Alzheimer's disease Aβ peptides
Ungureanu, A.-A., Benilova, I., Bael, M. J. V., Haesendonck, C. V., & Bartic, C. (2012) · IEEE International Conference on Nanotechnology (IEEE-NANO) · doi:10.1109/nano.2012.6322180 · Cited by 4
Self-citationBallesteros‐Álvarez, J., Nguyen, W., Sivapatham, R., Rane, A., & Andersen, J. K. (2022) · Research Square · doi:10.21203/rs.3.rs-2046848/v1 · Cited by 4
Linking higher amyloid beta 1‐38 (Aβ(1‐38)) levels to reduced Alzheimer's disease progression risk
Schneider, L., Freiesleben, S. D., van Breukelen, G., Wang, X., Brosseron, F., Heneka, M. T., Teipel, S. J., Kleineidam, L., Stark, M., Roy‐Kluth, N., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14545 · Cited by 3
Yu, L., Wang, X., Doan, T. H., Fan, Y., Bussière, T., Bacskai, B. J., & Kastanenka, K. V. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01812-9 · Cited by 3
Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibrils
Purvinsh, Y., Matveyenka, M., & Kurouski, D. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00934 · Cited by 3
Menon, R. S., Wolynes, P. G., & Vekilov, P. G. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c03842 · Cited by 3
Presenilin 1 deficiency impairs Aβ42-to-Aβ40- and angiotensin-converting activities of ACE
Gao, Y., Sun, Y., Islam, S., Nakamura, T., Tomita, T., Zou, K., & Michikawa, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1098034 · Cited by 4
RAGE-Mediated Effects of Formaldehyde in Alzheimer’s Disease
Mikhailov, I. G., Mikhailova, M. S., Shuvaev, А. N., Gorina, Y. V., & Belozor, О. S. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604593 · Cited by 3
New pathway links γ‐secretase to inflammation and memory while sparing notch
Gandy, S., & Wustman, B. A. (2010) · Annals of Neurology · doi:10.1002/ana.22310 · Cited by 3
More than a FAD: The In Vivo Effects of Disease-Linked Presenilin-1 Mutations
Zahs, K. R., & Ashe, K. H. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.021 · Cited by 3
Immunohistochemical detection of the delayed formation of nonfibrillar large amyloid‐β aggregates
Ochiishi, T., Itakura, A., Liu, L., Akatsu, H., Kohno, H., Nishimura, M., & Yoshimune, K. (2016) · Genes to Cells · doi:10.1111/gtc.12332 · Cited by 3
Namchaiw, P., Bunreangsri, P., Eiamcharoen, P., Eiamboonsert, S., & Poo-arporn, R. P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273458 · Cited by 3
Morisaku, T., & Yui, H. (2017) · Analytical Sciences · doi:10.2116/analsci.33.79 · Cited by 3
How many amyloid‐β peptides can a neuron bind before it dies?
Munter, L. M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13502 · Cited by 3
Membrane dynamics of Notch-bound γ-secretase produces two distinct Notch conformationsPreprint
Tang, N., Dehury, B., & Kepp, K. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/607846 · Cited by 3
Salta, E., Walgrave, H., Balusu, S., Eynden, E. V., Snoeck, S., Craessaerts, K., Thrupp, N., Wolfs, L., Horré, K., Fourne, Y., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.12.988709 · Cited by 3
Self-citationMolecular Determinants of Protein Pathogenicity at the Single‐Aggregate Level
Urbanek, A. N., Garland, E. F., Prescott, E. E., King, M. C., Olerinyova, A., Wareing, H. E., Georgieva, N., Bradshaw, E. L., Tzokov, S. B., Knight, A., et al. (2025) · Advanced Science · doi:10.1002/advs.202410229 · Cited by 3
Amyloid‐β Seeds in Alzheimer's Disease: Research Challenges and Implications
Beschörner, N., Xu, Y., Jucker, M., & Ruiz‐Riquelme, A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70267 · Cited by 2
Yata, V. K., Das, O. P., Dansana, J., Gadtya, A., Meher, B. R., Bukke, S. P. N., & Kolliputi, N. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1709505 · Cited by 2
Functions of the basal lamina and ApoE in cerebral amyloid angiopathy
Juan-Palencia, A., & Yao, Y. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00734-w · Cited by 2
Decoding the mechanisms of amyloid-β in synaptic toxicity
Toruński, P., Pizzirusso, G., Winblad, B. G., & Arroyo‐García, L. E. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261424292 · Cited by 2
Bauer, C., Duplan, E., George‐Hyslop, P. S., & Checler, F. (2023) · Cells · doi:10.3390/cells12242802 · Cited by 2
Wang, X., Dong, B., Song, Y., Wang, Z., Wang, Y., Xu, J., & Xue, C. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250145 · Cited by 2
Could ecosystem management provide a new framework for Alzheimer's disease?
Hubin, E., Vanschoenwinkel, B. J., Broersen, K., Deyn, P. P. D., Koedam, N. E., van Nuland, N. A. J., & Pauwels, K. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.491 · Cited by 2
Self-citationLi, X., Dong, X., Liu, Y., Meng, Y., Zhang, Y., Zhang, D., & Liu, C. (2016) · New Journal of Chemistry · doi:10.1039/c6nj02004f · Cited by 2
Duyckaerts, C. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.007 · Cited by 2
Stefani, I. C., de Thé, F.-X. B., Kontoravdi, C., & Polizzi, K. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112001 · Cited by 2
Mitochondria in Alzheimer disease : regulatory mechanisms and cell death
Hedskog, L. (2012) · Figshare · Cited by 2
Salivary biomarkers for neurodegenerative disorder for biomedical sensing
Singhal, A., Devi, R., Parihar, A., & Khan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00011-9 · Cited by 1
Tammara, V., & Das, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00357 · Cited by 1
The Role of Thionine on Amyloid Precursor Protein Processing in N2a-APPSwe Cells
Önder, S., Biberoğlu, K., & Tacal, Ö. (2025) · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi · doi:10.47572/muskutd.1698250 · Cited by 1
Griffin, M. N., Dinakarapandian, D. M., Li, C., Ramaswamy, P., Saheba, S. J., Lee, J., Sudarshan, T. R., Sajimon, M., Wheeler, C. J., Raskatov, J. A., et al. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00024 · Cited by 1
Anschuetz, A., Listyono, R., Vorley, T., Platt, B., Harrington, C. R., Riedel, G., & Schwab, K. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin48581 · Cited by 1
Choi, J.-S., & Hur, J. (2026) · DNA and Cell Biology · doi:10.1177/10445498261456523 · Cited by 1
Sarti, G., Tognozzi, G., Magni, G., Lana, D., Rossi, F., Traini, C., & Vannucchi, M. G. (2026) · Nutrients · doi:10.3390/nu18121883 · Cited by 1
Contribution of Nucleic Acids in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00004-5 · Cited by 1
Shahnawaz, M., & Soto, C. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816475-4.00020-3 · Cited by 1
Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis
Leroy, M., Aziz, A. L., Schraen‐Maschke, S., Deramecourt, V., Skrobala, E., Lecerf, S., Pasquier, F., Huin, V., Bertoux, M., & Lebouvier, T. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.02.004 · Cited by 1
Fukase, K., Iida-Adachi, A., & Nabika, H. (2025) · ACS Omega · doi:10.1021/acsomega.5c02756 · Cited by 1
Kabbani, M. A. A., Köhler, L., Wied, T., Adam, D., Klimek, J., & Zempel, H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18081038 · Cited by 1
Teng, T. (2014) · Submitted by the University of Missouri--Columbia Graduate School · Cited by 1
Alzheimer’s Disease and Mechanism-Based Attempts to Enhance Cognition
Draffin, J. E., Knafo, S., & Heneka, M. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00009-7 · Cited by 1
Caprelli, M. T. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1260-17.2017 · Cited by 1
Epitope Mapping by NMR of a Novel Anti-Aβ Antibody (STAB-MAb)
Posado-Fernández, A., Afonso, C. F., Dória, G., Flores, O., & Cabrita, E. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47626-2 · Cited by 1
Amyloid-β aggregates induced by β-cholesteryl glucose-embedded liposomes.
Shimanouchi, T., Sano, Y., Yasuhara, K., & Kimura, Y. (2022) · Biochimica et Biophysica Acta - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140816 · Cited by 1
Inclusion Bodies in the Study of Amyloid Aggregation
Villar‐Piqué, A., & Ventura, S. (2014) · Wiley eBooks · doi:10.1002/9781118845363.ch4 · Cited by 1
AN IN SILICO DESCRIPTION OF AN ALZHEIMER NETWORK
Rotgerink, J. L. (2013) · Cited by 1
The dynamic nature of amyloid-beta protein aggregation and its association to Alzheimer’s disease
Vilaprinyó-Pascual, S. (2015) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents
Ingólfsdóttir, I. E. (2013)
Regulation of expression and cellular release of acetylcholinesterase
Hicks, D. A. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Global Approaches to Understanding Protein Kinase Functions
Gorman, J. L., & Woodgett, J. R. (2015) · Wiley eBooks · doi:10.1002/9783527683031.ch1
Deciphering cell signaling rewiring in human disordersPreprint
Kuperstein, I. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1512.05234
Self-citationGolde, T. E., Lessard, C. B., & Ran, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00005-8
The Interaction Between Gamma-Secretase And Its Inhibitors And Modulators – Structural Insights
Gertsik, N. (2016) · eCommons (Cornell University)
Amyloid aggregates: detection and interaction
Rahman, M. M. (2018) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Hu, Q. (2016) · TSpace (University of Toronto)
Muhsen, Z., & Ali, M. A. M. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.210
McKeever, P. M. (2018) · TSpace (University of Toronto)
Vilar, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.330607
Alzheimer’s disease as a syndrome of overloaded amyloidic synaptic tagging in memory networksPreprint
Murphy, N. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/7gsaz
A Computational Approach to Understand the Interactions Stabilizing the Aβ1-42 Oligomers
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.88048817
Ballesteros‐Álvarez, J., Nguyen, W., Sivapatham, R., Rane, A., & Andersen, J. K. (2022) · Research Square · doi:10.21203/rs.3.rs-2046848/v2
Eccles, M. K., Groth, D., Verdile, G., & Agostino, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.17.541079
Chemical Underpinnings of Alzheimer’s Disease Symptoms and Causative Factors: A Systematic Review
Kim, C., & Sharma, M. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v12i3.4896
Arterial Aging, Blood Pressure, and Brain Damage
Scuteri, A., Debette, S., & Avolio, A. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00030-1
Gorgij, F., Nouri, H., & Ghahghaei, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4157212/v1
Using Chiroptical Spectroscopy to Gain Unique Information about the Solid‐State
Kuroda, R. (2024) · Wiley eBooks · doi:10.1002/9783527841110.ch30
Lloyd, C., Freskgård, P., Newton, P., Lowne, D., Nickson, A. A., Bogstedt, A., Eketjäll, S., Höglund, K., Gustavsson, S., Welsh, F., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14238
Zahraee, H., Arab, S. S., Parvaee, E., Mohammadi, F., Abnous, K., Taghdisi, S. M., & Khoshbin, Z. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126658
David, S., Salazar, D., Cantillo, P. P., & Barrera-Ocampo, A. A. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107182
STED-FCS in subdiffraction limit volumes reveals altered diffusion in live cell applications
Zobiak, B., Andres‐Alonso, M., Wang, Y., Mohammadi, B., Gorzelanny, C., Altmeppen, H., Yin, S.-T., & Failla, A. (2025) · bioRxiv · doi:10.1515/mim-2025-0032
Amyloid β hypothesis in the development of therapeutic agents for Alzheimer's disease
Adeniji, A. O., Johnson, C., & Mody, V. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00020-x
Metadata
- Authors
- Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., Braeken, D., Callewaert, G., Bartic, C., D'Hooge, R., Martins, I. C., Rousseau, F., Schymkowitz, J., & De Strooper, B.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Vrije Universiteit Brussel (BE)
- Rega Institute for Medical Research (BE)
- University of Twente (NL)
- IMEC (BE)
- Corresponding author
- Schymkowitz, Joost
- ORCID
- Venue
- The EMBO Journal
- Published
- 2010-09-03
- Volume
- 29
- Issue
- 19
- Pages
- 3408-3420
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC2957213
- OpenAlex
- W1966694507
- Cited by
- 532
- References
- 61
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 36 · 2023: 39 · 2022: 27 · 2021: 39 · 2020: 32 · 2019: 33 · 2018: 31 · 2017: 35 · 2016: 48 · 2015: 31 · 2014: 30 · 2013: 42 · 2012: 43
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- VU Research Portal (publishedVersion)
- University of Twente Research Information (publishedVersion, other-oa)
- Lirias (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- University of Twente Research Information (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission (200611)
- Fonds Wetenschappelijk Onderzoek (P6/43)
- Vlaamse regering
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, Aβ42/Aβ40 ratio, neurotoxicity, oligomeric intermediates, fibril morphology, synaptic dysfunction, neuronal cell death, anti-amyloid therapy, peptide mixtures
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Biophysics, Fluorescent Dyes, Humans, Kinetics, Microelectrodes, Neurons, Peptide Fragments, Protein Binding, Thiazoles, Amyloid beta-Peptides, Spectroscopy, Fourier Transform Infrared, Patch-Clamp Techniques, Microscopy, Electron, Transmission, Mice, Benzothiazoles, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
